Cargando…
PSUN276 GLP1RAs use for treating NALFD in a multidisciplinary clinic in low socioeconomic community
: GLP1RAs have been proven beneficial for weight loss in patients with NAFLD with or without Diabetes. However, such use is limited due to cost and limited insurance coverage in those without diabetes. Method: Retrospective chart review of patients with NAFLD seen at Multidisciplinary NAFLD clinic...
Autores principales: | West, Brittany, Mon, Sann, Myint, Alex, Lees, Heather |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627257/ http://dx.doi.org/10.1210/jendso/bvac150.836 |
Ejemplares similares
-
PSUN246 Pilot Study: Impact of discharge follow up care at endocrine clinic on glycemic control and re-admission rate in a community hospital
por: Gangavarapu, Praveen, et al.
Publicado: (2022) -
RF04 | PSUN295 Evolution of Monomeric Multi-Agonists of GLP-1 and NPY Receptors
por: Chichura, Kylie, et al.
Publicado: (2022) -
PSUN134 Loss of Glp-1r Signaling in the β-Cell Impairs Adaptive Proliferation and Insulin Secretion
por: Olvera, Angela, et al.
Publicado: (2022) -
RF28 | PSUN182 Risk of Pancreatitis After Glp-1 Receptor Agonist in Individuals With Known History of Pancreatitis
por: Kodali, Alimitha M, et al.
Publicado: (2022) -
PSUN172 Prescribing SGLT-2 Inhibitors and GLP-1 Agonists in Primary Care: Improving Rates of Guideline-Concordant Practice
por: Schuetz, Samantha, et al.
Publicado: (2022)